Effects of in vitro-Digested Ginsenosides on Lipid Accumulation in 3T3-L1 Adipocytes

Abstract

Ginseng, the root of Panax ginseng C. A. Meyer, is frequently used in traditional oriental medicines. The major active components of ginseng are the saponins, which are also called ginsenosides and are known for their pharmacological and biological activities. In this study, the effects of ginsenosides on lipid accumulation in 3T3-L1 adipocytes were investigated after the ginsenosides were in vitro-digested with artificial gastric and intestinal fluids. Ginseng extract was incubated with an artificial digestive fluid, and the changes were analyzed by HPLC, after which the effects of the digest on 3T3-L1 adipocytes were observed. Polar ginsenosides were transformed into less-polar ginsenosides at the low pH of the gastric acid, without any influence from the digestive enzymes. Additionally, the artificially digested ginsenosides showed inhibitory effects on lipid accumulation in 3T3-L1 adipocytes. When the 3T3-L1 adipocytes were treated with various ginseng samples that possessed different polarities, the less polar ginsenosides were more effective in reducing lipid accumulation. Furthermore, when the Rg3, Rk1, and Rg5 ginsenosides were used to treat the cells individually, Rg3 ginsenoside was the most effective at inhibiting lipid accumulation. These results suggest that the less polar ginsenosides, particularly ginsenoside Rg3, effectively reduce lipid accumulation in adipocytes. Accordingly, our results suggest that ginsenoside Rg3 should be developed as an antiobesity treatment.

Key words

ginseng - Panax ginseng C. A. Meyer - Araliaceae - ginsenoside - in vitro‐digestion - obesity - 3T3‐L1 adipocytes

References

• 1 Kim D H, Moon Y S, Lee T H, Jung J S, Suh H W, Song D K. The inhibitory effect of ginseng saponins on the stress-induced plasma interleukin-6 level in mice.  Neurosci Lett. 2003;  353 13-16
• 2 Kim H S, Lee E H, Ko S R, Choi K J, Park J H, Im D S. Effects of ginsenosides Rg3 and Rh2 on the proliferation of prostate cancer cells.  Arch Pharm Res. 2004;  27 429-435
• 3 Xie J T, Mehendale S R, Li X, Quigg R, Wang X, Wang C Z, Wu J A, Aung H H, Rue A P, Bell G I, Yuan C S. Anti-diabetic effect of ginsenoside Re in ob/ob mice.  Biochim Biophys Acta. 2005;  1740 319-325
• 4 Yun S N, Moon S J, Ko S K, Im B O, Chung S H. Wild ginseng prevents the onset of high fat diet induced hyperglycemia and obesity in ICR mice.  Arch Pharm Res. 2004;  27 790-796
• 5 Nisoli E, Carruba M O. Emerging aspects of pharmacotherapy for obesity and metabolic syndrome.  Pharmacol Res. 2004;  50 453-469
• 6 Furuyashiki T, Nagayasu H, Aoki Y, Bessho H, Hashimoto T, Kanazawa K, Ashida H. Tea catechin suppresses adipocyte differentiation accompanied by down-regulation of PPARγ₂ and C/EBPα in 3T3-L1 cells.  Biosci Biotechnol Biochem. 2004;  68 2353-2359
• 7 Kim M S, Park J Y, Namkoong C, Jang P G, Ryu J W, Song H S, Yun J Y, Namgoong I S, Ha J, Park I S, Lee I K, Viollet B, Youn J H, Lee H K, Lee K U. Anti-obesity effects of alpha-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase.  Nat Med. 2004;  10 727-733
• 8 Lee Y S, Kim W S, Kim K H, Yoon M J, Cho H J, Shen Y, Ye J M, Lee C H, Oh W K, Kim C T, Hohnen-Behrens C, Gosby A, Kraegen E W, James D E, Kim J B. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states.  Diabetes. 2006;  55 2256-2264
• 9 Karu N, Reifen R, Kerem Z. Weight gain reduction in mice fed Panax ginseng saponin, a pancreatic lipase inhibitor.  J Agric Food Chem. 2007;  55 2824-2828
• 10 Kim J H, Hahm D H, Yang D C, Lee H J, Shim I. Effect of crude saponin of Korean red ginseng on high-fat diet-induced obesity in the rat.  J Pharmacol Sci. 2005;  97 124-131
• 11 Pearson W, Orth M W, Karrow N A, Maclusky N J, Lindinger M I. Anti-inflammatory and chondroprotective effects of nutraceuticals from Sasha's Blend in a cartilage explant model of inflammation.  Mol Nutr Food Res. 2007;  51 1020-1030
• 12 Rimar S, Lee-Mengel M, Gillis C N. Pulmonary protective and vasodilator effects of a standardized Panax ginseng preparation following artificial gastric digestion.  Pulm Pharmacol. 1996;  9 205-209
• 13 Argyri K, Proestos C, Komaitis M, Kapsokefalou M. Phenolic compounds in red wine digested in vitro in the presence of iron and other dietary factors.  Int J Food Sci Nutr. 2005;  56 213-222
• 14 Janisch K M, Olschlager C, Treutter D, Elstner E F. Simulated digestion of Vitis vinifera seed powder: polyphenolic content and antioxidant properties.  J Agric Food Chem. 2006;  54 4839-4848
• 15 Ha Y W, Lim S S, Ha I J, Na Y C, Seo J J, Shin H, Son S H, Kim Y S. Preparative isolation of four ginsenosides from Korean red ginseng (steam-treated Panax ginseng C. A. Meyer), by high-speed counter-current chromatography coupled with evaporative light scattering detection.  J Chromatogr A. 2007;  1151 37-44
• 16 Kim S N, Ha Y W, Shin H, Son S H, Wu S J, Kim Y S. Simultaneous quantification of 14 ginsenosides in Panax ginseng C.A. Meyer (Korean red ginseng) by HPLC-ELSD and its application to quality control.  J Pharm Biomed Anal. 2007;  45 164-170
• 17 Park J D. Recent studies on the chemical constituents of Korean ginseng (Panax ginseng C.A.Meyer).  Korean J Ginseng Sci. 1996;  20 389-415
• 18 Popovich D G, Kitts D D. Generation of ginsenosides Rg3 and Rh2 from North American ginseng.  Phytochemistry. 2004;  65 337-344
• 19 Ko S R, Choi K J, Uchida K, Suzuki Y. Enzymatic preparation of ginsenosides Rg2, Rh1, and F1 from protopanaxatriol-type ginseng saponin mixture.  Planta Med. 2003;  69 285-286
• 20 Bae E A, Han M J, Kim E J, Kim D H. Transformation of ginseng saponins to ginsenoside Rh2 by acids and human intestinal bacteria and biological activities of their transformants.  Arch Pharm Res. 2004;  27 61-67